
Recent developments with PDS Biotechnology Corporation (PDSB) have led to the company’s beta value being reach 1.24 cents.
On Tuesday, PDS Biotechnology Corporation (NASDAQ: PDSB) was 8.51% up from the session before settling in for the closing price of $1.41. A 52-week range